Hepatitis A/B vaccination of adults over 40 years old: Comparison of three vaccine regiments and effect of influencing factors
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F06%3A00001467" target="_blank" >RIV/60162694:G44__/06:00001467 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Hepatitis A/B vaccination of adults over 40 years old: Comparison of three vaccine regiments and effect of influencing factors
Original language description
Challenged by contrasting data on low immune responses in the elderly with a combined hepatitis A/B vaccine, a randomised, controlled study was conducted to assess the immunogenicity of three hepatitis A and B vaccination regimens (group 1: combined hepatitis A/B vaccine Twinrix# [GSK]; group 2: co-administered hepatitis A vaccine, Havrix# [GSK] + hepatitis B vaccine Engerix#-B [GSK], group 3: co-administered hepatitis A vaccine, Vaqta# [Sanofi-Pasteur MSD] + hepatitis B vaccine HB VAX PRO# [Sanofi-Pasteur MSD]) and the effect of influencing factors in subjects >40 years. On completion of the full vaccination course, anti-HBs seroprotection (SP) rates were 92, 80 and 71% in groups 1, 2 and 3, respectively; anti-HAV seropositivity (S+) rates were 97, 99and 99%, respectively. In group 1, anti-HBs SP rate was non-inferior as well as superior and anti-HAV S+ rate was non-inferior to that in groups 2 and 3. Anti-HBs response was most significantly influenced by the vaccine regimen, followe
Czech name
Očkování proti virovým hepatitidám A a B u osob starších 40 let: Srovnání tří vakcín a posouzení působení ovlivňujících faktorů
Czech description
Očkování proti virovým hepatitidám A a B u osob starších 40 let: Srovnání tří vakcín a posouzení působení ovlivňujících faktorů.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FN - Epidemiology, infection diseases and clinical immunology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2006
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Vaccine
ISSN
0264-410X
e-ISSN
—
Volume of the periodical
24
Issue of the periodical within the volume
26
Country of publishing house
GB - UNITED KINGDOM
Number of pages
7
Pages from-to
5509-5515
UT code for WoS article
—
EID of the result in the Scopus database
—